10x Genomics, Inc. (TXG)
| Market Cap | 2.94B |
| Revenue (ttm) | 642.82M |
| Net Income (ttm) | -43.54M |
| Shares Out | 127.75M |
| EPS (ttm) | -0.35 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,756,592 |
| Open | 21.58 |
| Previous Close | 22.13 |
| Day's Range | 21.21 - 23.11 |
| 52-Week Range | 6.78 - 23.56 |
| Beta | 2.24 |
| Analysts | Hold |
| Price Target | 16.82 (-27.03%) |
| Earnings Date | Feb 12, 2026 |
About TXG
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium p... [Read more]
Financial Performance
In 2025, 10x Genomics's revenue was $642.82 million, an increase of 5.25% compared to the previous year's $610.79 million. Losses were -$43.54 million, -76.16% less than in 2024.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for TXG stock is "Hold." The 12-month stock price target is $16.82, which is a decrease of -27.03% from the latest price.
News
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
PLEASANTON, Calif., Feb. 19, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in...
Torex Gold Resources Inc. (TXG:CA) Q4 2025 Earnings Call Transcript
Torex Gold Resources Inc. (TXG:CA) Q4 2025 Earnings Call Transcript
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
PLEASANTON, Calif., Feb. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year e...
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- ...
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
PLEASANTON, Calif., Jan. 22, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and f...
10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc.
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to pow...
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next generati...
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth qu...
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinical...
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the...
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region PLEASANTON, Calif. and SYDNEY , Nov. 18, 2025 /PRNewswir...
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
PLEASANTON, Calif. , Nov. 11, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i...
10x Genomics, Inc. (TXG) Q3 2025 Earnings Call Transcript
10x Genomics, Inc. ( TXG) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Cassie Corneau - Manager of Investor Relations & Strategic Finance Serge Saxonov - Co-Founder, CEO & ...
10x Genomics Reports Third Quarter 2025 Financial Results
PLEASANTON, Calif. , Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September ...
Torex Gold Resources Inc. (TXG:CA) Q3 2025 Earnings Call Transcript
Torex Gold Resources Inc. ( TXG:CA) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Dan Rollins - Senior Vice President of Corporate Development & Investor Relations Jody Kuze...
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies PLEASANTON, Calif. , Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc...
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader ...
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
PLEASANTON, Calif. , Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended ...
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
SEATTLE--(BUSINESS WIRE)--Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent.
10x Genomics, Inc. (TXG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
10x Genomics, Inc. (NASDAQ:TXG) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants Serge Saxonov - Co-Founder, CEO & Director Conference Call...
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow procedure...
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i...